Skip to main content

Galante Joseph C's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Jun 10, 2022

Accession no.
0001209191-22-035994
Filed
Jun 10, 2022
Trade date
May 2-31, 2022
Filing delay
39 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $3.31K. It was filed 39 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Galante Joseph CCIK 0001632384Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 2, 2022Common StockPPurchaseAcquired+61$2.45+$149.4545,763Direct
May 3, 2022Common StockPPurchaseAcquired+61$2.42+$147.6245,824Direct
May 4, 2022Common StockPPurchaseAcquired+61$2.37+$144.5745,885Direct
May 5, 2022Common StockPPurchaseAcquired+61$2.35+$143.3545,946Direct
May 6, 2022Common StockPPurchaseAcquired+61$2.36+$143.9646,007Direct
May 9, 2022Common StockPPurchaseAcquired+68$2.63+$178.8446,075Direct
May 10, 2022Common StockPPurchaseAcquired+68$2.55+$173.446,143Direct
May 11, 2022Common StockPPurchaseAcquired+68$2.37+$161.1646,211Direct
May 12, 2022Common StockPPurchaseAcquired+68$2.23+$151.6446,279Direct
May 13, 2022Common StockPPurchaseAcquired+68$2.32+$157.7646,347Direct
May 16, 2022Common StockPPurchaseAcquired+68$2.31+$157.0846,415Direct
May 17, 2022Common StockPPurchaseAcquired+68$2.35+$159.846,483Direct
May 18, 2022Common StockPPurchaseAcquired+68$2.31+$157.0846,551Direct
May 19, 2022Common StockPPurchaseAcquired+68$2.29+$155.7246,619Direct
May 20, 2022Common StockPPurchaseAcquired+68$2.23+$151.6446,687Direct
May 23, 2022Common StockPPurchaseAcquired+76$2.17+$164.9246,763Direct
May 24, 2022Common StockPPurchaseAcquired+76$2.17+$164.9246,839Direct
May 25, 2022Common StockPPurchaseAcquired+76$2.15+$163.446,915Direct
May 26, 2022Common StockPPurchaseAcquired+76$2.12+$161.1246,991Direct
May 27, 2022Common StockPPurchaseAcquired+76$2.13+$161.8847,067Direct
May 31, 2022Common StockPPurchaseAcquired+76$2.13+$161.8847,143Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)